2007
DOI: 10.1111/j.1872-034x.2007.00290.x
|View full text |Cite
|
Sign up to set email alerts
|

C‐Phycocyanin ameliorates 2‐acetylaminofluorene induced oxidative stress and MDR1 expression in the liver of albino mice

Abstract: 2-AAF-induced oxidative stress is reduced by C-PC treatment. C-PC inhibited the 2-AAF induced expression of MDR1 by interfering at the level of ROS generation, Akt phosphorylation and NF-kappaB translocation. This study reveals the usefulness of C-PC in preventing oxidative stress and downregulation of MDR1 induced by xenobiotics like 2-AAF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…Phycocyanin inhibited the expression of the acetylaminofluorene-induced multidrug resistance protein (MDR1) in the mouse macrophage cell line RAW 264.7 in vitro by scavenging ROS [232] and in the liver of albino mice in vivo by interfering at the level of ROS generation, Akt (protein kinase B) phosphorylation and NF-κB translocation [233]. The same mechanisms (downregulation of ROS and COX-2 pathways via the involvement of NF-κB and activator protein 1 -AP-1, inhibition of MDR1) were confirmed in HepG2 human hepatocarcinoma cell line in relation to prevention of doxorubicin resistance by phycocyanin [126].…”
Section: Other Miscellaneous Medicinal Effectsmentioning
confidence: 99%
“…Phycocyanin inhibited the expression of the acetylaminofluorene-induced multidrug resistance protein (MDR1) in the mouse macrophage cell line RAW 264.7 in vitro by scavenging ROS [232] and in the liver of albino mice in vivo by interfering at the level of ROS generation, Akt (protein kinase B) phosphorylation and NF-κB translocation [233]. The same mechanisms (downregulation of ROS and COX-2 pathways via the involvement of NF-κB and activator protein 1 -AP-1, inhibition of MDR1) were confirmed in HepG2 human hepatocarcinoma cell line in relation to prevention of doxorubicin resistance by phycocyanin [126].…”
Section: Other Miscellaneous Medicinal Effectsmentioning
confidence: 99%
“…22 However, regarding purified phycocyanin, it was shown an MDR1 gene down-regulation in 2-AAF-causes liver tumors in the first day's treatment. 23 Also, phycocyanin inhibits tumor cell proliferation, and it arrests the tumor cell cycle into G 0 /G 1 through the mitogen-activated protein kinase (MAPK) pathway in vitro models. 24 Despite all findings about spirulina and phycocyanin antitumorigenic action, it is necessary to carry on studies in vivo without tumorigenic drugs, to define the effect of phycocyanin on an experimental model of liver cancer.…”
Section: Introductionmentioning
confidence: 99%